New Cancer Vaccine Developed, Going to Start Human Trial

Stanford University is now going to start human trial which includes 15 lymphomas patients with a new cancer therapy that can prime the immune system to eradicate tumors around the body. This treatment cured mice of lymphoma in 87 out of 90 cases and other three mice saw a return, which was successfully treated with a second dose. Similar results were seen in mice with breast, colon and melanoma cancers.The experiment used two immune-stimulating agents to boost cancer-fighting T-cells.readmore@MedStanford